Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome

Clinical trial NCT02297945 · COMPLETED

Trial details

NCT number: NCT02297945
Sponsor: HRA Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cushing's Syndrome

Start date: 2015-04-01
Primary completion: 2019-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.